The ground-breaking success of the mRNA vaccines against COVID-19 has radically changed how this technology is viewed and has reinvigorated research into a multitude of potential applications of mRNA, including vaccines against other diseases.
The benefits of mRNA-based therapies are multiple and could set a new standard for what we consider to be targeted, bespoke and effective medicines.
For our insight on the regulation of mRNA vaccines and other future therapies, including an in-depth look at how the mRNA-based COVID-19 vaccines were approved, please see Spotlight on mRNA – Regulation of mRNA vaccines and therapies. This article is part of our Spotlight on mRNA series which can be found on On The Pulse, our site dedicated to views on matters shaping life sciences.
Pre-pandemic, the technology was viewed with scepticism – a clever concept, but not guaranteed to deliver. Now there is growing confidence that mRNA vaccines could have far-reaching applications in tackling diseases from flu to malaria.